Trastuzumab deruxtecan in previously treated patients with HER2-positive metastatic breast cancer: updated survival results from a phase II trial (DESTINY-Breast01)
☆
Title:
Trastuzumab deruxtecan in previously treated patients with HER2-positive metastatic breast cancer: updated survival results from a phase II trial (DESTINY-Breast01)
☆
Author:
Saura, C. Modi, S. Krop, I. Park, Y.H. Kim, S.-B. Tamura, K. Iwata, H. Tsurutani, J. Sohn, J. Mathias, E. Liu, Y. Cathcart, J. Singh, J. Yamashita, T.